BI201335

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI201335, covering 2013-02-26 to 2013-02-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C Infection [Phase 3]

See pricing